Genetically-engineered mouse models for pancreatic cancer: Advances and current limitations

Hideaki Ijichi1

  • 1Hideaki Ijichi, Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Summary

Genetically-engineered mouse models accurately mimic human pancreatic cancer progression. Studying these models offers insights into pancreatic ductal adenocarcinoma (PDAC) mechanisms for improved diagnostics and therapies.